期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 1, 页码 441-451出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm901420x
关键词
-
Efforts to enhance the inhibitory potency of the initial purine series of fructose-1,6-bisphosphatase (FBPase) inhibitors led to the discovery of it series of benzirniclazole analogues with hurnan FBPase IC50S < 100 nM. I nhibitor 4.4 emerged as a lead compound based on its potent inhibition of hurnan liver FBPase (IC5() = 55 ilM) and significant glucose lowering in nornial fasted rats. Intravenous administration of 4.4 to Zucker diabetic fatty rats led to rapid and robust glucose lowering, thereby providing the first evidence that FBPase inhibitors could improve glycernia in animal models of type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据